Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Jan;4(1):5-9.
doi: 10.1159/000335999. Epub 2012 Jan 11.

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate

Masaya Ishibashi  1 , Taku Fujimura, Akira Hashimoto, Takahiro Haga, Kaoru Onami, Akira Tsukada, Yumi Kambayashi, Takanori Hidaka, Sadanori Furudate, Ryoko Shimada, Setsuya Aiba
Affiliations
Case Reports

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate

Masaya Ishibashi et al. Case Rep Dermatol. 2012 Jan.

Abstract

We describe a 78-year-old Japanese patient with angiosarcoma on the scalp. Interestingly, immunohistochemical staining revealed this tumor as positive for matrix metalloproteinase 9 (MMP-9). After conventional therapy for angiosarcoma with surgical treatment and radiation therapy, we intravenously administered docetaxel at 40 mg/m(2) body surface area together with oral administration of 17.5 mg sodium risedronate hydrate. One and a half years after the standard treatment, there was no evidence of local recurrence or metastasis.

Keywords: Angiosarcoma; Bisphosphonate; Docetaxel; MMP-9.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A skin-colored nodule with surgery scar, teleangiectasia and purpura on the scalp.
Fig. 2
Fig. 2
Irregular anastomosing vascular channel lined by a single layer of enlarged endothelial cells between collagen bundles with dense infiltration of lymphocytes. (a ×50; b ×200; original magnification).
Fig. 3
Fig. 3
Enlarged endothelial-like cells and tumor stromas were positive for MMP-9. (×200; original magnification).
See this image and copyright information in PMC

References

    1. Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, Murakami M, Kawabe T, Ejima Y, Matsumoto A, Sugimura K. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys. 2002;15:1032–1040. - PubMed
    1. Ward JR, Feigenberg SJ, Mendenhall NP, Marcus RB, Mendenhall WM. Radiation therapy for angiosarcoma. Head Neck. 2003;25:873–878. - PubMed
    1. Koontz BF, Miles EF, Rubio MA, Madden JF, Fisher SR, Scher RI, Brizel DM. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head and Neck. 2008;30:262–266. - PubMed
    1. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer and Metastasis Rev. 2004;23:101–117. - PubMed
    1. Murakami M, Sakai H, Kodama A, Yanai T, Mori T, Maruo K, Masegi T. Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcoma. Histol Histopathol. 2009;24:437–446. - PubMed

Publication types